552 related articles for article (PubMed ID: 27507552)
1. Muscle expression of a malonyl-CoA-insensitive carnitine palmitoyltransferase-1 protects mice against high-fat/high-sucrose diet-induced insulin resistance.
Vavrova E; Lenoir V; Alves-Guerra MC; Denis RG; Castel J; Esnous C; Dyck JR; Luquet S; Metzger D; Bouillaud F; Prip-Buus C
Am J Physiol Endocrinol Metab; 2016 Sep; 311(3):E649-60. PubMed ID: 27507552
[TBL] [Abstract][Full Text] [Related]
2. Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis.
Monsénégo J; Mansouri A; Akkaoui M; Lenoir V; Esnous C; Fauveau V; Tavernier V; Girard J; Prip-Buus C
J Hepatol; 2012 Mar; 56(3):632-9. PubMed ID: 22037024
[TBL] [Abstract][Full Text] [Related]
3. Increasing mitochondrial muscle fatty acid oxidation induces skeletal muscle remodeling toward an oxidative phenotype.
Hénique C; Mansouri A; Vavrova E; Lenoir V; Ferry A; Esnous C; Ramond E; Girard J; Bouillaud F; Prip-Buus C; Cohen I
FASEB J; 2015 Jun; 29(6):2473-83. PubMed ID: 25713059
[TBL] [Abstract][Full Text] [Related]
4. Carnitine palmitoyltransferase I (CPT I) activity and its regulation by malonyl-CoA are modulated by age and cold exposure in skeletal muscle mitochondria from newborn pigs.
Schmidt I; Herpin P
J Nutr; 1998 May; 128(5):886-93. PubMed ID: 9566999
[TBL] [Abstract][Full Text] [Related]
5. Regulation of muscle malonyl-CoA levels in the nutritionally insulin-resistant desert gerbil, Psammomys obesus.
Shafrir E; Ziv E; Saha AK; Ruderman NB
Diabetes Metab Res Rev; 2002; 18(3):217-23. PubMed ID: 12112940
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of carnitine palmitoyltransferase-1 activity alleviates insulin resistance in diet-induced obese mice.
Keung W; Ussher JR; Jaswal JS; Raubenheimer M; Lam VH; Wagg CS; Lopaschuk GD
Diabetes; 2013 Mar; 62(3):711-20. PubMed ID: 23139350
[TBL] [Abstract][Full Text] [Related]
7. Expression of genes regulating malonyl-CoA in human skeletal muscle.
Pender C; Trentadue AR; Pories WJ; Dohm GL; Houmard JA; Youngren JF
J Cell Biochem; 2006 Oct; 99(3):860-7. PubMed ID: 16721829
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids.
Akkaoui M; Cohen I; Esnous C; Lenoir V; Sournac M; Girard J; Prip-Buus C
Biochem J; 2009 May; 420(3):429-38. PubMed ID: 19302064
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of hypothalamic fatty acid synthase triggers rapid activation of fatty acid oxidation in skeletal muscle.
Cha SH; Hu Z; Chohnan S; Lane MD
Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14557-62. PubMed ID: 16203972
[TBL] [Abstract][Full Text] [Related]
10. Malonyl-CoA and the regulation of fatty acid oxidation in soleus muscle.
Alam N; Saggerson ED
Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):233-41. PubMed ID: 9693125
[TBL] [Abstract][Full Text] [Related]
11. Demonstration of N- and C-terminal domain intramolecular interactions in rat liver carnitine palmitoyltransferase 1 that determine its degree of malonyl-CoA sensitivity.
Faye A; Borthwick K; Esnous C; Price NT; Gobin S; Jackson VN; Zammit VA; Girard J; Prip-Buus C
Biochem J; 2005 Apr; 387(Pt 1):67-76. PubMed ID: 15498023
[TBL] [Abstract][Full Text] [Related]
12. Increased mitochondrial fatty acid oxidation is sufficient to protect skeletal muscle cells from palmitate-induced apoptosis.
Henique C; Mansouri A; Fumey G; Lenoir V; Girard J; Bouillaud F; Prip-Buus C; Cohen I
J Biol Chem; 2010 Nov; 285(47):36818-27. PubMed ID: 20837491
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial long chain fatty acid oxidation, fatty acid translocase/CD36 content and carnitine palmitoyltransferase I activity in human skeletal muscle during aerobic exercise.
Holloway GP; Bezaire V; Heigenhauser GJ; Tandon NN; Glatz JF; Luiken JJ; Bonen A; Spriet LL
J Physiol; 2006 Feb; 571(Pt 1):201-10. PubMed ID: 16357012
[TBL] [Abstract][Full Text] [Related]
14. Alteration of the malonyl-CoA/carnitine palmitoyltransferase I interaction in the beta-cell impairs glucose-induced insulin secretion.
Herrero L; Rubí B; Sebastián D; Serra D; Asins G; Maechler P; Prentki M; Hegardt FG
Diabetes; 2005 Feb; 54(2):462-71. PubMed ID: 15677504
[TBL] [Abstract][Full Text] [Related]
15. Controlling skeletal muscle CPT-I malonyl-CoA sensitivity: the importance of AMPK-independent regulation of intermediate filaments during exercise.
Miotto PM; Steinberg GR; Holloway GP
Biochem J; 2017 Feb; 474(4):557-569. PubMed ID: 27941154
[TBL] [Abstract][Full Text] [Related]
16. Malonyl-CoA and carnitine palmitoyltransferase I: an expanding partnership.
McGarry JD
Biochem Soc Trans; 1995 Aug; 23(3):481-5. PubMed ID: 8566378
[No Abstract] [Full Text] [Related]
17. Binding of malonyl-CoA to isolated mitochondria. Evidence for high- and low-affinity sites in liver and heart and relationship to inhibition of carnitine palmitoyltransferase activity.
Bird MI; Saggerson ED
Biochem J; 1984 Sep; 222(3):639-47. PubMed ID: 6487267
[TBL] [Abstract][Full Text] [Related]
18. Dietary fatty acids influence the activity and metabolic control of mitochondrial carnitine palmitoyltransferase I in rat heart and skeletal muscle.
Power GW; Newsholme EA
J Nutr; 1997 Nov; 127(11):2142-50. PubMed ID: 9349840
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance.
Bruce CR; Hoy AJ; Turner N; Watt MJ; Allen TL; Carpenter K; Cooney GJ; Febbraio MA; Kraegen EW
Diabetes; 2009 Mar; 58(3):550-8. PubMed ID: 19073774
[TBL] [Abstract][Full Text] [Related]
20. Malonyl CoA as a metabolic switch and a regulator of insulin sensitivity.
Ruderman NB; Saha AK; Vavvas D; Kurowski T; Laybutt DR; Schmitz-Peiffer C; Biden T; Kraegen EW
Adv Exp Med Biol; 1998; 441():263-70. PubMed ID: 9781332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
